Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Current Leases (2020 - 2025)

Mainz Biomed's Current Leases history spans 5 years, with the latest figure at $280145.0 for Q4 2024.

  • For Q4 2024, Current Leases fell 2.88% year-over-year to $280145.0; the TTM value through Dec 2024 reached $280145.0, down 2.88%, while the annual FY2024 figure was $280145.0, 2.88% down from the prior year.
  • Current Leases for Q4 2024 was $280145.0 at Mainz Biomed, down from $288463.0 in the prior quarter.
  • Across five years, Current Leases topped out at $288463.0 in Q4 2023 and bottomed at $47611.0 in Q4 2020.
  • The 5-year median for Current Leases is $280145.0 (2024), against an average of $191329.8.
  • The largest annual shift saw Current Leases skyrocketed 418.11% in 2022 before it dropped 2.88% in 2024.
  • A 5-year view of Current Leases shows it stood at $47611.0 in 2020, then rose by 15.68% to $55076.0 in 2021, then surged by 418.11% to $285354.0 in 2022, then grew by 1.09% to $288463.0 in 2023, then decreased by 2.88% to $280145.0 in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Current Leases are $280145.0 (Q4 2024), $288463.0 (Q4 2023), and $285354.0 (Q4 2022).